Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Wayne Brinster Joins WHEATON® as President

Published: Friday, October 26, 2012
Last Updated: Friday, October 26, 2012
Bookmark and Share
The company will continue its focus on supporting laboratory research, and packaging for diagnostics and specialty pharmaceutical markets.

WHEATON has announced the appointment of Wayne Brinster to the role of president, succeeding Stephen R, Drozdow, who remains as chief executive officer.

Mr. Brinster brings to the position a familiar, science-driven focus while sharing Mr. Drozdow’s long-time commitment to WHEATON customers, suppliers, partners and employees.

Mr. Brinster comes to WHEATON from Synthon Pharmaceuticals, a privately owned manufacturer of pharmaceutical and biopharmaceutical products, where he served as vice president and general manager.

Prior to Synthon, Mr. Brinster worked in different management roles for over 30 years at Becton, Dickinson and Company, where he most recently led the BD Diagnostics Women’s Health and Cancer Care initiative.

“Having spent most of my life in the business of science, I am excited to be here with a leading name in the field, joining an organization that has developed a reputation for supporting important scientific achievements,” said Mr. Brinster.

“By leveraging technical knowledge with excellent customer service, we’re going to continue placing WHEATON at the forefront of the industry,” he added.

Mr. Drozdow, after leading WHEATON since 1996, will become the chief executive officer and will continue to have an active role at WHEATON, working closely with Mr. Brinster on matters pertaining to strategy, key industry relationships, finance, budgets and acquisitions. “Wayne is a great business leader,” said Mr. Drozdow. “He understands the science of our markets, knows our industry and identifies with our approach to customers.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

WHEATON® Acquires Chromatography Vial Supply Company, MicroLiter
A specialty brand joins forces with an established industry leader resulting in an expanding product line and support services for the global HPLC market.
Friday, December 21, 2012
WHEATON® Announces Acquisition of CELLine™
WHEATON has acquired the CELLine bioreactor flask line for antibody and protein production from Wilson Wolf Manufacturing Corporation.
Tuesday, July 10, 2012
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!